TVM Life Science Ventures VI GmbH & Co KG Insider Trading $CNCE CONCERT PHARMACEUTICALS, INC.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for TVM Life Science Ventures VI GmbH & Co KG.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of TVM Life Science Ventures VI GmbH & Co KG. TVM Life Science Ventures VI GmbH & Co KG is Director in Acer Therapeutics Inc. ($OPXA) and Director in CONCERT PHARMACEUTICALS, INC. ($CNCE) and 10% Owner in PROTEON THERAPEUTICS INC ($PRTO).

TVM Life Science Ventures VI GmbH & Co KG in CONCERT PHARMACEUTICALS, INC.

Trading Symbol: CNCE
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of TVM Life Science Ventures VI GmbH & Co KG: Director
Holdings: 378,703 shares
Current Value: $3,389,392
Latest Transaction: Feb 20 2014
$CNCE Market Capitalization: $197.12M
$CNCE Previous Close: $8.95

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of TVM Life Science Ventures VI GmbH & Co KG in CONCERT PHARMACEUTICALS, INC.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, ACER, CNCE, TARA

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Feb 20 2014CNCECONCERT PHARMACEUT ...TVM Life Science Ventures VI G ...DirectorOption ExerciseC0.00288,40700
Feb 20 2014CNCECONCERT PHARMACEUT ...TVM Life Science Ventures VI G ...DirectorOption ExerciseC0.001,084,81300
Feb 20 2014CNCECONCERT PHARMACEUT ...TVM Life Science Ventures VI G ...DirectorOption ExerciseC0.00561,55000
Feb 20 2014CNCECONCERT PHARMACEUT ...TVM Life Science Ventures VI G ...DirectorOption ExerciseC0.00841,49300
Feb 20 2014CNCECONCERT PHARMACEUT ...TVM Life Science Ventures VI G ...DirectorOption ExerciseC0.003,165,18700
Feb 20 2014CNCECONCERT PHARMACEUT ...TVM Life Science Ventures VI G ...DirectorOption ExerciseC0.001,638,45000
Feb 20 2014CNCECONCERT PHARMACEUT ...TVM Life Science Ventures VI G ...DirectorBuyP14.0022,713317,982378,703356 K to 378.7 K (+6.38 %)
Feb 20 2014CNCECONCERT PHARMACEUT ...TVM Life Science Ventures VI G ...DirectorBuyP14.0066,287928,0181,104,9691 M to 1.1 M (+6.38 %)
Feb 20 2014CNCECONCERT PHARMACEUT ...TVM Life Science Ventures VI G ...DirectorBuyC0.0051,0450355,990304.9 K to 356 K (+16.74 %)
Feb 20 2014CNCECONCERT PHARMACEUT ...TVM Life Science Ventures VI G ...DirectorBuyC0.00192,0030304,945112.9 K to 304.9 K (+170.00 %)
Feb 20 2014CNCECONCERT PHARMACEUT ...TVM Life Science Ventures VI G ...DirectorBuyC0.0099,3890112,94213.6 K to 112.9 K (+733.34 %)
Feb 20 2014CNCECONCERT PHARMACEUT ...TVM Life Science Ventures VI G ...DirectorBuyC0.00148,93601,038,682889.7 K to 1 M (+16.74 %)
Feb 20 2014CNCECONCERT PHARMACEUT ...TVM Life Science Ventures VI G ...DirectorBuyC0.00560,2110889,746329.5 K to 889.7 K (+170.00 %)
Feb 20 2014CNCECONCERT PHARMACEUT ...TVM Life Science Ventures VI G ...DirectorBuyC0.00289,9910329,53539.5 K to 329.5 K (+733.34 %)

Page:   1